Dry granulation offers several advantages to manufacturers and it’s now attracting more attention with the push towards continuous manufacturing.

Will 3D inkjet printing enable the manufacture of personalized tablets?

Can artificial approaches trump the conventions of traditional organic synthesis for the production of raw pharmaceutical products within cells?

The game “Tumor Quest” seeks to improve people’s understanding of cancer.

Microfluidics technology has room for improvement, but can undoubtedly impact protein analysis.

Delays arising from formulation issues are commonplace in the industry. It’s time to start thinking about the problem earlier.

As novel technologies begin to make inroads into the biopharma industry, we have to consider what will come next and how beneficial it will be.

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

As a leading partner and supplier to the industry, MilliporeSigma continues to strengthen and enhance its supply chain capabilities.

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.